Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (371-380 of 2,960) with videos related to

Pageof 296
Sort By:
American Journal of Clinical Pathology|July 1, 1989
Special report: a simple system for the derivation of International Normalized Ratios for the reporting of prothrombin time results with North American thromboplastin reagentsL Poller, J Hirsh
Journal of Pharmaceutical Sciences|September 1, 1982
Chelation of mercury by polymercaptal microspheres: new potential antidote for mercury poisoningS Margel, J Hirsh
Journal of Molecular Biology|June 14, 1971
Translation of the UGA triplet in vitro by tryptophan transfer RNA'sD Hirsh, L Gold
Physiology & Behavior|June 1, 1972
Complete transection of the fornix and reversal of position habit in the ratR Hirsh, M Segal
Nature|April 8, 1976
Non-ageing developmental variant of Caenorhabditis elegansM Klass, D Hirsh
Chest|September 24, 2004
Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyJack Hirsh, Robert Raschke
Thrombosis and Haemostasis|July 1, 1997
Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical resultsJ Hirsh, M Crowther
Archives of Neurology|November 1, 1986
Therapeutic range for the control of oral anticoagulant therapyJ Hirsh, M Levine
Thrombosis and Haemostasis|February 28, 1979
Definition of high risk/high response population for stroke in patients with transient ischemic attacksM Gent, J Hirsh
Frontiers in Oncology|August 8, 2014
Chemotherapy in Metastatic NSCLC - New Regimens (Pemetrexed, Nab-Paclitaxel)Normand Blais, Vera Hirsh
Pageof 296

Showing results (371-380 of 2,960) with videos related to

Sort By:
Pageof 296
American Journal of Clinical Pathology|July 1, 1989
Special report: a simple system for the derivation of International Normalized Ratios for the reporting of prothrombin time results with North American thromboplastin reagentsL Poller, J Hirsh
Journal of Pharmaceutical Sciences|September 1, 1982
Chelation of mercury by polymercaptal microspheres: new potential antidote for mercury poisoningS Margel, J Hirsh
Journal of Molecular Biology|June 14, 1971
Translation of the UGA triplet in vitro by tryptophan transfer RNA'sD Hirsh, L Gold
Physiology & Behavior|June 1, 1972
Complete transection of the fornix and reversal of position habit in the ratR Hirsh, M Segal
Nature|April 8, 1976
Non-ageing developmental variant of Caenorhabditis elegansM Klass, D Hirsh
Chest|September 24, 2004
Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyJack Hirsh, Robert Raschke
Thrombosis and Haemostasis|July 1, 1997
Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical resultsJ Hirsh, M Crowther
Archives of Neurology|November 1, 1986
Therapeutic range for the control of oral anticoagulant therapyJ Hirsh, M Levine
Thrombosis and Haemostasis|February 28, 1979
Definition of high risk/high response population for stroke in patients with transient ischemic attacksM Gent, J Hirsh
Frontiers in Oncology|August 8, 2014
Chemotherapy in Metastatic NSCLC - New Regimens (Pemetrexed, Nab-Paclitaxel)Normand Blais, Vera Hirsh
Pageof 296